Brief: Diasorin Q1 Adj. EBITDA EUR 90 Mln
May 8 (Reuters) - DiaSorin SpA DIAS.MI: CONFIRMS 2026 GUIDANCE Q1 ADJUSTED EBITDA EUR 90 MILLION Q1 REVENUE EUR 287 MILLION Q1 NET PROFIT EUR 38 MILLION Further company coverage: DIAS.MI (Reporting by Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48587696600;))
Recent news on DiaSorin SpA
See all newsKepler sees European Medtech recovery, starts BioMerieux at 'Buy' as top pick
Brief: Diasorin Receives Us' FDA 510(K) Clearance And Clia Waiver For Liaison Nes Group A Streptococcus (Gas) Assay
Deutsche Bank cuts Diasorin to 'sell', sees company targets as stretched
Italy - Factors to watch on June 5
Italy's DiaSorin jumps after Betaville reports possible takeover interest